Literature DB >> 5146573

Thymidylate synthetase. Model studies of inhibition by 5-trifluoromethyl-2'-deoxyuridylic acid.

D V Santi, T T Sakai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5146573     DOI： 10.1021/bi00795a018

Source DB:  PubMed          Journal:  Biochemistry        ISSN： 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  12 in total

Review 1.  TAS-102, a novel antitumor agent: a review of the mechanism of action.

Authors:  Heinz-Josef Lenz; Sebastian Stintzing; Fotios Loupakis
Journal:  Cancer Treat Rev       Date:  2015-06-06       Impact factor: 12.111

2.  5-Fluoro-2'-deoxyuridylate: covalent complex with thymidylate synthetase.

Authors:  D V Santi; C S McHenry
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

3.  Trifluridine selectively inhibits cell growth and induces cell apoptosis of triple-negative breast cancer.

Authors:  Juan Li; Jie Liu; Riqi Wang; He Chen; Cui Li; Minggang Zhao; Fang He; Yaochun Wang; Peijun Liu
Journal:  Am J Cancer Res       Date:  2020-02-01       Impact factor: 6.166

4.  Interaction of tRNA (uracil-5-)-methyltransferase with NO2Ura-tRNA.

Authors:  X Gu; A Matsuda; K M Ivanetich; D V Santi
Journal:  Nucleic Acids Res       Date:  1996-03-15       Impact factor: 16.971

Review 5.  Therapeutic potential of TAS-102 in the treatment of gastrointestinal malignancies.

Authors:  Godefridus J Peters
Journal:  Ther Adv Med Oncol       Date:  2015-11       Impact factor: 8.168

Review 6.  Privileged Electrophile Sensors: A Resource for Covalent Drug Development.

Authors:  Marcus John Curtis Long; Yimon Aye
Journal:  Cell Chem Biol       Date:  2017-06-22       Impact factor: 8.116

7.  Panitumumab interaction with TAS-102 leads to combinational anticancer effects via blocking of EGFR-mediated tumor response to trifluridine.

Authors:  Yuji Baba; Toshiya Tamura; Yoshihiko Satoh; Masamitsu Gotou; Hiroshi Sawada; Shunsuke Ebara; Kazunori Shibuya; Jumpei Soeda; Kazuhide Nakamura
Journal:  Mol Oncol       Date:  2017-05-30       Impact factor: 6.603

8.  Radiosynthesis of the anticancer nucleoside analogue Trifluridine using an automated 18F-trifluoromethylation procedure.

Authors:  Alice King; Andreas Doepner; David Turton; Daniela M Ciobota; Chiara Da Pieve; Anne-Christine Wong Te Fong; Gabriela Kramer-Marek; Yuen-Li Chung; Graham Smith
Journal:  Org Biomol Chem       Date:  2018-04-25       Impact factor: 3.876

9.  Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs.

Authors:  Ren Sun; Liya Wang
Journal:  BMC Microbiol       Date:  2013-08-06       Impact factor: 3.605

Review 10.  Emerging combination therapies for metastatic colorectal cancer - impact of trifluridine/tipiracil.

Authors:  Jeevan M Puthiamadathil; Benjamin A Weinberg
Journal:  Cancer Manag Res       Date:  2017-10-03       Impact factor: 3.989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.